23andMe ft. Anne Wojcicki - How a DNA startup took on the FDA and redefined health tech
Listen now
Description
Millions of customers have explored their genome with 23andMe. But when the company started in 2006, the idea of consumer DNA testing was heresy to the medical establishment. The FDA once even ordered 23andMe to stop selling its health testing product. The company persevered to make allies out of adversaries, and became the only FDA-approved product on the market. Learn how 23andMe defined the DNA testing category, and used its success to enter the massive new field of drug discovery.    Host: Roelof Botha, Sequoia Capital  Featuring: Anne Wojcicki, Richard Scheller  Transcript: https://www.sequoiacap.com/podcast/crucible-moments-23andMe/ Learn more about your ad choices. Visit podcastchoices.com/adchoices
More Episodes
Tony Xu and Miki Kuusi share insights from building two of the world's most successful delivery platforms—DoorDash and Wolt—which merged in 2022 to create an $80B GOV business operating in 32 countries. In this candid conversation with Sequoia's Alfred Lin live at a Sequoia event in Europe, they...
Published 11/14/24
DoorDash faced skeptics from the start. Grubhub, Delivery.com, and others were already addressing the restaurant delivery market when CEO Tony Xu and his co-founders started in 2013. But after talking to hundreds of local small businesses, they realized there was still an unmet need: None of the...
Published 10/24/24
Published 10/24/24